Pfizer is the world’s leading biopharmaceutical company with a diversified global health care portfolio that includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world's best-known consumer products. Pfizer is one of Ireland's leading employers and the largest pharmaceutical sector investor and employer. One of the first pharmaceutical companies to locate in Ireland (1969), Pfizer has a rich heritage of innovation and expansion over a forty-year period. The business has almost 4,500 colleagues across 11 locations based in Cork, Dublin, Kildare and Limerick. Pfizer’s business interests in Ireland are diverse. There is a manufacturing presence in Active Pharmaceutical Ingredients, Solid Dose Pharmaceuticals, Sterile Injectibles, Nutritionals, Vaccines and Biopharmaceuticals; commercial Human Prescription, Animal Health and Consumer Health products businesses; Global Financial Services centre and a global Treasury operation. The Irish operations manufacture some of Pfizer’s best selling and newest medicines. Ireland is a leading manufacturing base for Pfizer globally, exporting to global markets. Total capital investment by the company in Ireland exceeds $7billion.

Pfizer joined I2E2 because, like many other manufacturing businesses energy is a huge cost and optimising that cost is key to long term competitiveness.  From an Irish perspective ICMR provides a n excellent  vehicle to achieve this goal.

Membership of I2E2 provides Pfizer with the opportunity to benchmark with leading manufacturing organisations in diverse businesses as well as working together to overcome common challenges in the area of energy optimisation.

Membership of I2E2 is aligned with Pfizer Global Supply’s mission to “provide fast, flexible and innovative supply solutions” as well as our commitment to protect the environment in which we operate.

Pfizer in Ireland faces the same competiveness challenges as other businesses and access to the advanced energy optimisation solutions will help Ireland to remain a key element of the Pfizer supply chain.